Products solutions prefilled syringes
fulvestrant

Fulveject 250 mg/5 ml solution for injection (fulvestrant, pre-filled syringe, 5 ml)    

Fulvestrant belongs to the group of estrogen blockers. Estrogens, a type of female sex hormones, can in some cases be involved in the growth of breast cancer.

Fulveject is used to treat advanced or metastatic breast cancer in postmenopausal women.




Code: L02BA03
Home   •   news   •   Farmacovigilance   •   About us   •   Contact ENRORU